In this review, we focus on one aspect of this signaling crosstalk, the impact of tumor cell and stromal cell-expressed PAR2 expression on TGF-β signaling and TGF-β-mediated cellular responses in PDAC-derived cancer cells and HCC-derived cancer and stromal cells. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.